CLINICAL_TRIALS
trial_result
· 2019-03-11
Clinical Trial Update: Staccato Prochlorperazine Thorough QT/QTc [Phase 1]
Summary
Phase 1 thorough QT/QTc study of Staccato Prochlorperazine completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Cardiotoxicity | Phase 1 | Status: COMPLETED | Results posted: 2019-03-11